LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling
LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling
About this item
Full title
Author / Creator
Xie, Xianghong , Gao, Mingyue , Zhao, Wei , Li, Chunmei , Zhang, Weihong , Yang, Jiahui , Zhang, Yinliang , Chen, Enhui , Guo, Yanfang , Guo, Zeyu , Zhang, Minglong , Ngowi, Ebenezeri Erasto , Wang, Heping , Wang, Xiaoman , Zhu, Yinghan , Wang, Yiting , Li, Xiaolu , Yao, Hong , Yan, Li , Fang, Fude , Li, Meixia , Qiao, Aijun and Liu, Xiaojun
Publisher
England: eLife Sciences Publications Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: eLife Sciences Publications Ltd
Subjects
More information
Scope and Contents
Contents
LncRNAs are involved in modulating the individual risk and the severity of progression in metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate the role of lncRNA
Snhg3
in the development and progression of MASLD, along with the underlying mechanisms. The...
Alternative Titles
Full title
LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_fb1fdb9a0fbb4456a2811b372765b02f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fb1fdb9a0fbb4456a2811b372765b02f
Other Identifiers
ISSN
2050-084X
E-ISSN
2050-084X
DOI
10.7554/eLife.96988
